In supply chain management, it is widely accepted that holding enough finished goods inventory to fulfill every order is just too costly. Ipsen, a global bio-pharmaceutical company , disproves that.
Wake Forest Baptist Health has begun drone deliveries of medicines and blood. As soon as a patient checks in at a Wake Forest Baptist Health infusion clinic, their specific medicine is created at the hospital and flown over via drone, creating an on-demand pharmacy for medicine with a short shelf life. Wake Forest Baptist has […]
Medtronic MDT has been engaged in a digital transformation. This includes building out a digital twin of their end-to-end supply chain to make it easier for people to make better and faster supply chain decisions. The company has built a data lake to feed LLamasoft’s Supply Chain Analytics Platform, llama.ai, to create their supply chain digital […]
While the impact of coronavirus on Indian industry has so far been moderate, India’s extremely high import dependence on China means there are significant ramifications for Indian industry. Of the top 20 products that India imports from around the world, the average Chinese share is close to 30 percent. Sectors in India that have been […]
Earlier this week, the death toll from the Wuhan coronavirus rose to over 1,000 people, invoking memories of the 2003 SARS outbreak. While the human aspect of this outbreak is clearly the biggest story, the virus is causing major disruptions in global supply chains as well. As my colleague Steve Banker pointed out yesterday, the global high-tech supply chain has been hit particularly hard. But other industries are feeling the impact as well.
A new head of supply chain at Pfizer asked a simple question, “If Amazon can provide end to end shipment status of my orders, why can’t Pfizer.” That was the impetus for a supply chain visibility project. “The company had to change their mindset and embrace a global orchestrated supply network.
Leading pharmaceutical and biotech companies must continue to adapt to increasing global competition, regulation, and pricing pressures. In response, the pharmaceutical industry is undergoing a major value chain transformation.